Contents
Download PDF
pdf Download XML
2156 Views
430 Downloads
Share this article
Letter to the Editor | Volume 1 Issue 1 (July-Dec, 2020) | Pages 1 - 2
Haplotypes and Mtdna Polymorphisms may not Determine the Penetrance of the M.11778g>a Primary Lhon Mutation
1
Klinikum Landstrasse, Messerli Institute, Vienna, Austria
Under a Creative Commons license
Open Access
Received
June 30, 2020
Revised
Aug. 2, 2020
Accepted
Sept. 21, 2020
Published
Oct. 5, 2020
Abstract

With interest we read the article by Piotrowska-Nowak et al. [1] about the influence of haplotypes and single nucleotide polymorphisms (SNPs) of the mitochondrial DNA (mtDNA) on the penetrance of the primary Leber’s hereditary optic neuropathy (LHON) mutation m.11778G>A in MT-ND4 in 47 unrelated Polish male patients. The authors concluded that haplogroup K and several mtDNA SNPs could determine the penetrance of this variant in the investigated cohort [1]. We have the following comments and concerns.

 

The authors are obviously not convinced about the significance of their results since the conclusions are speculative. The sample size is definitively too small to draw conclusions about the influence of the haplotype or SNPs on the penetrance of the primary LHON mutation m.11778G>A. From 5 patients carrying the haplotype K (11%) it cannot be calculated that haplotype K is responsible for the penetrance of the primary LHON mutation m.11778G>A. Furthermore, the distribution of SNPs in LHON patients and controls is not convincing as a factor determining the m.11778G> penetrance. There was no difference in the number of transitions and transversions between the two groups. The increased number of SNPs in the complex-IV regions in controls argues against causality. One would expect and increased number of SNPs in the patient group. Additionally, one would rather expect and increased number of SNPs in complex-1 regions but not complex-IV regions. 

 

We do not agree with the statement that “symptoms in LHON are limited to a single organ” [1]. LHON, like all other mitochondrial disorders (MIDs), is a multisystem disease, either already at onset of the disease or becomes a multisystem condition during the disease course. Though being a mono-organ condition in the vast majority of the cases at onset, several other organs or tissues become affected in LHON with progression of the disease (LHON plus) [2,3]. Only rarely, is spontaneous recovery of the abnormalities observed [4].

 

We do not agree with the notion that LHON is the most common MID [1]. The most common of the MIDs are the non-syndromic MIDs. Among the syndromic MIDs the most common is mitochondrial encephalopathy, lactic acidosis and stroke-like episode (MELAS) syndrome. Prevalence figures of syndromic MIDs vary largely between countries and regions.

 

We also do not agree with the statement that “the optic nerve is the tissue affected in LHON” [1]. The primary site of affection is the retina [5] where the primary pathophysiologic processes occur in the retinal ganglion cells (RGCs). Their neurites are secondarily affected leading degeneration and thus   secondary optic atrophy [5].

 

Unclear remains if all 47 included patients also manifested clinically or were asymptomatic carriers of the m.11778G>A variant. It is also unclear how many of the included patients received idebenone or not.            

 

Overall, the study has a number of shortcomings which need to be addressed before drawing final conclusions. The authors could not unequivocally demonstrate that haplotypes or mtDNA SNPs significantly influence the penetrance of the m.11778G>A variant. Since the vast majority of the respiratory chain complex-1 (RCC-1) subunits are nuclearly encoded, it is more likely that SNPs in nDNA genes encoding RCC-1 subunits than mtDNA SNPs influence the penetrance of the m.11778G>A variant. Warranted are more in-depth studies on the function of RCC-1 subunits and how the nuclear background influences the penetrance of mtDNA variants.

Keywords
REFERENCE
  1. Piotrowska-Nowak, A. et al. "Mitochondrial genome variation in male LHON patients with the m.11778G > A mutation." Metabolic Brain Disease, 2020, doi:10.1007/s11011-020-00605-3.

  2. Finsterer, J., and Zarrouk-Mahjoub, S. "Leber's hereditary optic neuropathy is multiorgan not mono-organ." Clinical Ophthalmology, vol. 10, 2016, pp. 2187–2190, doi:10.2147/OPTH.S120197.

  3. Mauri, E. et al. "Subclinical Leber's hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye." BMC Neurology, vol. 18, no. 1, 2018, p. 220, doi:10.1186/s12883-018-1227-9.

  4. Lam, B. L. et al. "Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: preparation for gene therapy clinical trial." JAMA Ophthalmology, vol. 132, no. 4, 2014, pp. 428–436, doi:10.1001/jamaophthalmol.2013.7971.

  5. Yu-Wai-Man, P., and Chinnery, P. F. "Leber hereditary optic neuropathy." In: Adam, M. P., Ardinger, H. H., Pagon, R. A. et al., eds. GeneReviews®. Seattle (WA), University of Washington, Seattle, October 26, 2000.
License
CC BY-NC-ND
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Haplotypes and Mtdna Polymorphisms may not Determine the Penetrance of the M.11778g>a Primary Lhon Mutation © 2026 by Josef Finsterer licensed under CC BY-NC-ND 4.0
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Himalayan Journal of Community Medicine and Public Health open access articles are licensed under a Creative Commons Attribution-Share A like 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Research Article
Study of fish quality in Hor Abu Zark 2021-2022
Published: 24/01/2024
Download PDF
Research Article
Etiological Analysis of the Incident of Computer Vision Syndrome (Cvs) in Students of the Faculty of Medical Muhammadiyah University Semarang
...
Published: 20/01/2026
Download PDF
Research Article
Otolaryngologic Perspective on Endoscopic Sellar Reconstruction after Transsphenoidal Pituitary Surgery
...
Published: 31/12/2025
Download PDF
Research Article
Pharmacological Prophylaxis of Deep Venous Thrombosis in Lower Limbs Long Bones Compound Fractures caused by Missile Injuries, in Comparison with no Prophylaxis
...
Published: 10/01/2026
Download PDF
Chat on WhatsApp
Flowbite Logo
Najmal Complex,
Opposite Farwaniya,
Kuwait.
Email: kuwait@iarcon.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Others
About Us
Team Members
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
Follow us
MOST SEARCHED KEYWORDS
scientific journal
 | 
business journal
 | 
medical journals
 | 
Scientific Journals
 | 
Academic Publisher
 | 
Peer-reviewed Journals
 | 
Open Access Journals
 | 
Impact Factor
 | 
Indexing Services
 | 
Journal Citation Reports
 | 
Publication Process
 | 
Impact factor of journals
 | 
Finding reputable journals for publication
 | 
Submitting a manuscript for publication
 | 
Copyright and licensing of published papers
 | 
Writing an abstract for a research paper
 | 
Manuscript formatting guidelines
 | 
Promoting published research
 | 
Publication in high-impact journals
Copyright © iARCON Internaltional LLP . All Rights Reserved.